Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 8, 2026Clinical & Translational OncologyOpen Access

Pharmacogenomic diversity in Amazonian Indigenous populations: implications for Berlin–Frankfurt–Münster acute lymphoblastic leukemia therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLuciana Pereira Colares LeitãoNMNatasha MonteJMJuliana Carla Rodrigues Marcellino

Discussion

Loading...

Member takes

Overview

Genomic analysis reveals unique drug-metabolizing gene variants in Amazonian Indigenous individuals, highlighting the importance of population-specific acute lymphoblastic leukemia protocols.

Key Points

  • To characterize pharmacogenomic diversity across drug metabolism and transport genes relevant to Berlin–Frankfurt–Münster leukemia therapy in Amazonian Indigenous populations.
  • Analyzed whole-exome sequencing data from 64 healthy Indigenous individuals across 12 Amazonian ethnic groups, focusing on 120 therapy-associated genes.
  • Annotated and filtered variants with bioinformatic quality controls, comparing allele frequencies against five 1000 Genomes Project continental populations using multidimensional scaling.
  • Identified 648 filtered variants, including 28 observed exclusively in the Indigenous cohort, four of which were nonsynonymous coding changes with predicted moderate impact.
  • Observed significant allele frequency divergence in ADA rs11555566, CBR3 rs881711, and CYP2B6 rs3745274, with rs881711 and rs3745274 differing from all five continental reference populations.
  • Multidimensional scaling demonstrated a distinct Indigenous pharmacogenomic profile that clustered closest to Admixed American cohorts.

Cite This Study

Leitão et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd82f58e84d0ff5b47751https://doi.org/10.1007/s12094-026-04562-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Investigation of Pharmacogenomic Variants in the CYP (P450) Family in Native American Populations of the Brazilian Amazon2026
  2. 2Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations2026
  3. 3Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations2024 · 1 citations
  4. 4Genetic Variation in <scp>ADHD</scp> ‐Related Risk Genes in an Indigenous Population of the Amazon2026
  5. 5Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations2025